HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiminori Hosoda Selected Research

FPFS-410

12/2004Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivative, FPFS-410.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiminori Hosoda Research Topics

Disease

21Obesity
04/2022 - 09/2002
15Insulin Resistance
01/2018 - 04/2005
14Type 2 Diabetes Mellitus (MODY)
10/2021 - 04/2005
8Body Weight (Weight, Body)
10/2021 - 12/2009
8Hypoglycemia (Reactive Hypoglycemia)
07/2021 - 09/2002
6Hypertension (High Blood Pressure)
11/2022 - 02/2007
6Neoplasms (Cancer)
01/2014 - 11/2002
5Dyslipidemias (Dyslipidemia)
10/2021 - 12/2004
5Hyperphagia (Overeating)
01/2017 - 03/2006
4Diabetes Mellitus
11/2022 - 12/2004
4Hyperglycemia
10/2014 - 12/2004
4Insulinoma
01/2013 - 11/2002
4Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
11/2012 - 05/2004
3Overweight
11/2022 - 10/2014
3Diabetes Complications
08/2018 - 02/2007
3Inflammation (Inflammations)
01/2017 - 05/2010
3Lipodystrophy
04/2016 - 10/2012
3Fatty Liver
09/2013 - 02/2010
3Glucagonoma
01/2013 - 11/2002
2Heart Failure
01/2022 - 03/2020
2Ischemic Stroke
07/2021 - 12/2018
2Glucose Intolerance
10/2019 - 09/2009
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
10/2019 - 08/2019
2Cardiovascular Diseases (Cardiovascular Disease)
08/2019 - 01/2019
2Hypertrophy
01/2018 - 04/2010
2Metabolic Diseases (Metabolic Disease)
01/2013 - 05/2009
2Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2010 - 02/2009
2Weight Gain
12/2009 - 09/2007
2Islet Cell Adenoma (Islet Cell Tumors)
12/2005 - 11/2002
1Anorexia
04/2022
1Ventricular Tachycardia
01/2022
1Atrial Fibrillation
01/2022
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2021
1Pathologic Constriction (Stenosis)
07/2021
1Alzheimer Disease (Alzheimer's Disease)
11/2020
1Cognitive Dysfunction
11/2020
1Heart Diseases (Heart Disease)
03/2020
1Left Ventricular Dysfunction
03/2020
1Atherosclerotic Plaque (Atheroma)
10/2019
1Atherosclerosis
08/2019
1Homozygous Familial Hypercholesterolemia
08/2019
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Sarcopenia
01/2019
1Stroke (Strokes)
12/2018
1Infertility (Sterility)
01/2017

Drug/Important Bio-Agent (IBA)

24Glucose (Dextrose)FDA LinkGeneric
10/2021 - 07/2004
15Insulin (Novolin)FDA Link
08/2018 - 09/2002
14LeptinIBA
04/2022 - 08/2005
8Triglycerides (Triacylglycerol)IBA
11/2022 - 04/2005
7LipidsIBA
04/2022 - 08/2005
6Blood Glucose (Blood Sugar)IBA
07/2021 - 04/2012
6GhrelinIBA
02/2012 - 09/2002
3Fatty Acids (Saturated Fatty Acids)IBA
01/2018 - 12/2005
3C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA
01/2018 - 05/2013
3AMP-Activated Protein KinasesIBA
11/2012 - 02/2009
3Hormones (Hormone)IBA
04/2012 - 02/2009
2LDL CholesterolIBA
11/2022 - 01/2019
23- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
10/2021 - 01/2020
2CanagliflozinIBA
10/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
10/2019 - 07/2014
2Biomarkers (Surrogate Marker)IBA
10/2019 - 09/2013
2Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
10/2019 - 10/2019
2Therapeutic UsesIBA
08/2019 - 11/2012
2Hypoglycemic Agents (Hypoglycemics)IBA
04/2017 - 04/2012
2Pharmaceutical PreparationsIBA
10/2016 - 02/2009
2Messenger RNA (mRNA)IBA
01/2013 - 12/2005
2AngiotensinogenIBA
09/2010 - 04/2010
2GlucocorticoidsIBA
05/2010 - 05/2009
2Growth Hormone (Somatotropin)IBA
09/2009 - 09/2007
2MelanocortinsIBA
07/2009 - 02/2009
1HDL CholesterolIBA
11/2022
1Sucrose (Saccharose)IBA
04/2022
1PlakophilinsIBA
01/2022
1Sodium-Glucose Transport ProteinsIBA
10/2021
1Sodium-Glucose Transporter 2 InhibitorsIBA
10/2021
1SodiumIBA
03/2020
1Ketone BodiesIBA
03/2020
16- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
03/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1Fatty Acid-Binding ProteinsIBA
10/2019
1SubtilisinIBA
10/2019
1LDL Receptors (LDL Receptor)IBA
10/2019
1HDL LipoproteinsIBA
10/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2019
1oxidized low density lipoproteinIBA
08/2019
1Lipoproteins (Lipoprotein)IBA
08/2019
1LinagliptinIBA
04/2019
1CholesterolIBA
08/2018
1Insulin Glargine (Lantus)FDA Link
04/2017
1Hemoglobins (Hemoglobin)IBA
04/2017
1insulin degludecIBA
04/2017
1Long-Acting Insulin (Insulin, Long Acting)FDA Link
04/2017
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2017

Therapy/Procedure

5Therapeutics
07/2021 - 02/2007
4Glycemic Control
07/2021 - 07/2014
1Electric Countershock (Cardioversion)
01/2022
1Renal Dialysis (Hemodialysis)
10/2021
1Blood Component Removal (Apheresis)
08/2019
1Injections
04/2017